Celesq® Programs

Mobile Apps and the New FDA Guidance for Mobile Medical App Developers: What In-House Counsel Should Know

Expired
Program Number
2404
Program Date
2014-01-16
CLE Credits
2

The FDA recently issued final guidance for developers on the regulation of mobile medical software applications (“apps”). The final guidance ends a more than 2-year process intended to clarify the FDA’s regulation of mobile medical apps and pave the way for even greater adoption of mobile medical technology. In this program geared especially for in-house counsel, Jason Haislmaier reviews and deciphers what the final guidance means for mobile medical app developers, addressing what questions have been answered by the final guidance; what issues remain unresolved; and what new questions have emerged.

Available in States

  • California
  • Colorado Eligible
  • Georgia
  • New Jersey Eligible
  • New York
  • Texas Self Study

Program Categories

  • Computer, Internet & E-Commerce Law
  • Corporate and Commercial Law
  • Data Security and Outsourcing
  • Health Care Law
  • Privacy Law
  • Regulatory and Administrative Law
  • Technology Law

PROGRAM CREDITS

  • Areas of Professional Practice : 1 Credit
  • 1.0 General CLE credit, based on a 60-minute credi : 1 Credit